|
| 37503126 | Understanding the genetic complexity of puberty timing across the allele frequency spectrum. | medRxiv | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37789226 | Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. | Eur J Epidemiol | 2023 |
| 37862240 | Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types. | JNCI Cancer Spectr | 2023 |
| 36824750 | Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. | Res Sq | 2023 |
| 36707629 | FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. | Eur J Hum Genet | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37444426 | Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. | Cancers (Basel) | 2023 |
| 37437607 | Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer. | Radiother Oncol | 2023 |
| 35084436 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 |
| 35840111 | No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity. | Int J Radiat Oncol Biol Phys | 2022 |
| 35654374 | Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 36303815 | A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. | Cancer Res Commun | 2022 |
| 35585550 | Breast cancer risks associated with missense variants in breast cancer susceptibility genes. | Genome Med | 2022 |
| 35647396 | Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort. | Adv Radiat Oncol | 2022 |
| 36356581 | Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics. | Am J Hum Genet | 2022 |
| 35554533 | Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach. | Hum Mol Genet | 2022 |
| 36206742 | Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. | Am J Hum Genet | 2022 |
| 35933885 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model. | Eur J Cancer | 2022 |
| 35418701 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. | Sci Rep | 2022 |
| 36328784 | Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. | Br J Sports Med | 2022 |
| 36130474 | Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort. | EBioMedicine | 2022 |
| 35543923 | Relevance of the MHC region for breast cancer susceptibility in Asians. | Breast Cancer | 2022 |
| 35723569 | Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies. | J Natl Cancer Inst | 2022 |
| 35468796 | Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification. | BMC Medicine | 2022 |
| 33811135 | Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and Singapore. | J Med Genet | 2022 |
| 35334417 | Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). | Lung Cancer | 2022 |
| 35042965 | Rare germline copy number variants (CNVs) and breast cancer risk. | Commun Biol | 2022 |
| 34906514 | Polygenic risk scores for prediction of breast cancer risk in Asian populations. | Genet Med | 2022 |
| 35143328 | Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast Cancer. | J Clin Oncol | 2022 |
| 34611289 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis. | Sci Rep | 2021 |
| 32359158 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. | J Natl Cancer Inst | 2021 |
| 34234117 | Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. | Nat Commun | 2021 |
| 34069208 | Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? | Cancers (Basel) | 2021 |
| 33473200 | Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33471991 | Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. | N Engl J Med | 2021 |
| 34275018 | Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium. | Eur J Epidemiol | 2021 |
| 33893315 | Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses. | NPJ Breast Cancer | 2021 |
| 33990587 | Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. | Nat Commun | 2021 |
| 34146516 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. | Am J Hum Genet | 2021 |
| 33769540 | Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. | J Natl Cancer Inst | 2021 |
| 33500318 | Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34341517 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk. | Br J Cancer | 2021 |
| 32851660 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. | Int J Cancer | 2021 |
| 32785646 | Common Susceptibility Loci for Male Breast Cancer. | J Natl Cancer Inst | 2021 |
| 33398198 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 34522458 | Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization study. | Am J Cancer Res | 2021 |
| 34407845 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. | Breast Cancer Res | 2021 |
| 34857041 | Germline breast cancer susceptibility genes, tumor characteristics, and survival. | Genome Med | 2021 |
| 31095341 | Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. | J Natl Cancer Inst | 2020 |